Resistant hypertension in nondialysis chronic kidney disease

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Borrelli, Silvio ^a   De Nicola, Luca ^a   Stanzione, Giovanna ^a   Conte, Giuseppe ^a   Minutolo, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; METOLAZONE; MINOXIDIL; SPIRONOLACTONE; VASODILATOR AGENT;

ABSENCE OF SIDE EFFECTS; ADRENERGIC ACTIVITY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANT HYPERTENSION; REVIEW; RISK FACTOR; SODIUM RESTRICTION; SODIUM RETENTION; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

EID: 84877984646     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/929183     Document Type: Review

References (67)

1. Calhoun D. A., Jones D., Textor S., Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008 117 25 510 526 2-s2.0-79959334521
2. Sarafidis P. A., Bakris G. L., Resistant hypertension: an overview of evaluation and treatment. Journal of the American College of Cardiology 2008 52 22 1749 1757 2-s2.0-56149084750 10.1016/j.jacc.2008.08.036
3. Persell S. D., Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011 57 6 1076 1080 2-s2.0-79956370902 10.1161/HYPERTENSIONAHA.111.170308
4. Pimenta E., Calhoun D. A., Resistant hypertension: incidence, prevalence, and prognosis. Circulation 2012 125 13 1594 1596
5. Hajjar I., Kotchen T. A., Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. Journal of the American Medical Association 2003 290 2 199 206 2-s2.0-0038690424 10.1001/jama.290.2.199 (Pubitemid 37430058)
6. Furberg C. D., Wright J. T., Davis B. R., Cutler J. A., Alderman M., Black H., Cushman W., Grimm R., Haywood L. J., Leenen F., Oparil S., Probstfield J., Whelton P., Nwachuku C., Gordon D., Proschan M., Einhom P., Ford C. E., Piller L. B., Dunn I. K., Goff D., Pressel S., Bettencourt J., DeLeon B., Simpson L. M., Blanton J., Geraci T., Walsh S. M., Nelson C., Rahman M., Juratovac A., Pospisil R., Carroll L., Sullivan S., Russo J., Barone G., Christian R., Feldman S., Lucente T., Calhoun D., Jenkins K., McDowell P., Johnson J., Kingry C., Alzate J., Margolis K. L., Holland-Klemme L. A., Jaeger B., Williamson J., Louis G., Ragusa P., Williard A., Ferguson R. L. S., Tanner J., Eckfeldt J., Crow R., Pelosi J., Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Journal of the American Medical Association 2002 288 23 2981 2997 2-s2.0-0344373794 10.1001/jama.288.23.2981 (Pubitemid 35471160)
7. Sarafidis P. A., Georgianos P., Bakris G. L., Resistant hypertension-its identification and epidemiology. Nature Reviews Nephrology 2012 9 1 51 58
8. Moser M., Setaro J. F., Resistant or difficult-to-control hypertension. The New England Journal of Medicine 2006 355 4 385 392 2-s2.0-33746430561 10.1056/NEJMcp041698 (Pubitemid 44127541)
9. El Nahas M., The global challenge of chronic kidney disease. Kidney International 2005 68 6 2918 2929 2-s2.0-32844463812 10.1111/j.1523-1755.2005. 00774.x (Pubitemid 43251055)
10. Klag M. J., Whelton P. K., Randall B. L., Neaton J. D., Brancati F. L., Ford C. E., Shulman N. B., Stamler J., Blood pressure and end-stage renal disease in men. The New England Journal of Medicine 1996 334 1 13 18 2-s2.0-0030034592 10.1056/NEJM199601043340103 (Pubitemid 26012498)
11. Jafar T. H., Stark P. C., Schmid C. H., Landa M., Maschio G., De Jong P. E., De Zeeuw D., Shahinfar S., Toto R., Levey A. S., Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition. A patient-level meta-analysis. Annals of Internal Medicine 2003 139 4 244 253 2-s2.0-0141789624
12. Sarnak M. J., Greene T., Wang X., Beck G., Kusek J. W., Collins A. J., Levey A. S., The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Annals of Internal Medicine 2005 142 5 342 351 2-s2.0-14344255910 (Pubitemid 40293407)
13. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England Journal of Medicine 2004 351 13 1296 1370 2-s2.0-4644221457 10.1056/NEJMoa041031 (Pubitemid 39268908)
14. De La Sierra A., Segura J., Banegas J. R., Gorostidi M., De La Cruz J. J., Armario P., Oliveras A., Ruilope L. M., Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011 57 5 898 902 2-s2.0-79955481070 10.1161/HYPERTENSIONAHA.110.168948
15. Mazzaglia G., Mantovani L. G., Sturkenboom M. C. J. M., Filippi A., Trifirò G., Cricelli C., Brignoli O., Caputi A. P., Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. Journal of Hypertension 2005 23 11 2093 2100 2-s2.0-29244462820 (Pubitemid 41830406)
16. Van Wijk B. L. G., Klungel O. H., Heerdink E. R., De Boer A., Rate and determinants of 10-year persistence with antihypertensive drugs. Journal of Hypertension 2005 23 11 2101 2107 2-s2.0-28844436931 (Pubitemid 41830407)
17. De Nicola L., Gabbai F. B., Agarwal R., Prevalence and prognostic role of resistant hypertension in Chronic Kidney Disease. Journal of the American College of Cardiology. In press
18. De Nicola L., Borrelli S., Gabbai F. B., Chiodini P., Zamboli P., Iodice C., Vitiello S., Conte G., Minutolo R., Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease. Kidney and Blood Pressure Research 2011 34 1 58 67 2-s2.0-78650875954 10.1159/000322923
19. De Nicola L., Chiodini P., Zoccali C., Prognosis of CKD patients receiving outpatient nephrology care in Italy. Clinical Journal of the American Society of Nephrology 2011 6 10 2421 2428
20. Marín R., Fernández-Vega F., Gorostidi M., COPARENAL (Control de la Hipertensión Arterial en Pacientes con Insuficiencia RENAL) study investigators. Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study. Journal of Hypertension 2006 24 395 402
21. Stevens P. E., O'Donoghue D. J., De Lusignan S., Van Vlymen J., Klebe B., Middleton R., Hague N., New J., Farmer C. K. T., Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney International 2007 72 1 92 99 2-s2.0-34347334551 10.1038/sj.ki.5002273 (Pubitemid 47014451)
22. Minutolo R., De Nicola L., Zamboli P., Chiodini P., Signoriello G., Toderico C., Arfè G., Boschi G., Brancati C., Iaccarino P., Conte G., Management of hypertension in patients with CKD: differences between primary and tertiary care settings. American Journal of Kidney Diseases 2005 46 1 18 25 2-s2.0-20544461108 10.1053/j.ajkd.2005.03.019 (Pubitemid 40848429)
23. Minutolo R., Sasso F. C., Chiodini P., Cianciaruso B., Carbonara O., Zamboli P., Tirino G., Pota A., Torella R., Conte G., Nicola L. D., Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings. Journal of Hypertension 2006 24 8 1655 1661 2-s2.0-33746764463 10.1097/01.hjh.0000239303.93872.31 (Pubitemid 44162469)
24. De Nicola L., Borrelli S., Chiodini P., Hypertension management in chronic kidney disease: translating guidelines into daily practice. Journal of Nephrology 2011 24 6 733 741
25. Minutolo R., Borrelli S., Scigliano R., Bellizzi V., Chiodini P., Cianciaruso B., Nappi F., Zamboli P., Conte G., De Nicola L., Prevalence and clinical correlates of white coat hypertension in chronic kidney disease. Nephrology Dialysis Transplantation 2007 22 8 2217 2223 2-s2.0-34547830308 10.1093/ndt/gfm164 (Pubitemid 47244699)
26. Minutolo R., Borrelli S., Chiodini P., Scigliano R., Bellizzi V., Cianciaruso B., Nappi F., Zamboli P., Catapano F., Conte G., De Nicola L., Effects of age on hypertensive status in patients with chronic kidney disease. Journal of Hypertension 2007 25 11 2325 2333 2-s2.0-35148823628 10.1097/HJH.0b013e3282ef549e (Pubitemid 47537928)
27. Campese V. M., Mitra N., Sandee D., Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney International 2006 69 6 967 973 2-s2.0-33644856338 10.1038/sj.ki.5000177 (Pubitemid 43372170)
28. De Nicola L., Minutolo R., Bellizzi V., Zoccali C., Cianciaruso B., Andreucci V. E., Fuiano G., Conte G., Achievement of target blood pressure levels in chronic kidney disease: a salty question? American Journal of Kidney Diseases 2004 43 5 782 795 2-s2.0-1942466547 10.1053/j.ajkd.2004.01.009 (Pubitemid 38529615)
29. Cianciaruso B., Bellizzi V., Minutolo R., Colucci G., Bisesti V., Russo D., Conte G., De Nicola L., Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. Journal of the American Society of Nephrology 1996 7 2 306 313 2-s2.0-0029881892 (Pubitemid 26092480)
30. Konishi Y., Okada N., Okamura M., Morikawa T., Okumura M., Yoshioka K., Imanishi M., Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin A nephropathy. Hypertension 2001 38 1 81 85 2-s2.0-0035572028 (Pubitemid 34224775)
31. Minutolo R., Agarwal R., Borrelli S., Chiodini P., Bellizzi V., Nappi F., Cianciaruso B., Zamboli P., Conte G., Gabbai F. B., De Nicola L., Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Archives of Internal Medicine 2011 171 12 1090 1098 2-s2.0-79960134730 10.1001/archinternmed.2011.230
32. Minutolo R., Gabbai F. B., Borrelli S., Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. American Journal of Kidney Diseases 2007 50 6 908 917 2-s2.0-36249003834 10.1053/j.ajkd.2007.07.020 (Pubitemid 350122805)
33. Sachdeva A., Weder A. B., Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006 48 4 527 533 2-s2.0-33750596187 10.1161/01.HYP.0000240268.37379.7c (Pubitemid 44843846)
34. Remuzzi G., Perico N., Macia M., Ruggenenti P., The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney International 2005 99 S57 S65 2-s2.0-33644970719
35. Turek N. F., Ricardo A. C., Lash J. P., Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. American Journal of Kidney Diseases 2012 60 823 833
36. Salles G. F., Cardoso C. R. L., Muxfeldt E. S., Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Archives of Internal Medicine 2008 168 21 2340 2346 2-s2.0-57149138527
37. Daugherty S. L., Powers J. D., Magid D. J., Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012 125 1635 1642
38. Salles G. F., Cardoso C. R., Pereira V. S., Fiszman R., Muxfeldt E. S., Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: A Cohort Study. Journal of Hypertension 2011 29 2014 2023
39. Salles G. F., Cardoso C. R. L., Fiszman R., Muxfeldt E. S., Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis 2011 216 1 199 204 2-s2.0-79955535485 10.1016/j.atherosclerosis.2011.01.026
40. Palmer B. F., Renal dysfunction complicating the treatment of hypertension. The New England Journal of Medicine 2002 347 16 1256 1261 2-s2.0-0037126333 10.1056/NEJMra020676 (Pubitemid 35176246)
41. Lewis J. B., Blood pressure control in chronic kidney disease: is less really more? Journal of the American Society of Nephrology 2010 21 7 1086 1092 2-s2.0-77954566304 10.1681/ASN.2010030236
42. Kao M. P., Ang D. S., Gandy S. J., Nadir M. A., Houston J. G., Lang C. C., Struthers A. D., Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. Journal of the American Society of Nephrology 2011 22 7 1382 1389 2-s2.0-79960141065 10.1681/ASN.2010111185
43. Christen A. I., Armentano R. L., Miranda A., Graf S., Santana D. B., Zócalo Y., Baglivo H. P., Sánchez R. A., Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings. Current Diabetes Reviews 2010 6 6 367 377 2-s2.0-79952277573
44. Weir M. R., Townsend R. R., Fink J. C., Hemodynamic correlates of proteinuria in chronic kidney disease. Clinical Journal of the American Society of Nephrology 2011 6 2403 2410
45. Sanders P. W., Vascular consequences of dietary salt intake. American Journal of Physiology 2009 297 2 F237 F243 2-s2.0-68049097209 10.1152/ajprenal.00027.2009
46. Sarnak M. J., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., McCullough P. A., Kasiske B. L., Kelepouris E., Klag M. J., Parfrey P., Pfeffer M., Raij L., Spinosa D. J., Wilson P. W., Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003 42 5 1050 1065 2-s2.0-0242441465 10.1161/01.HYP.0000102971. 85504.7c (Pubitemid 37413751)
47. Agarwal R., Light R. P., GFR, proteinuria and circadian blood pressure. Nephrology Dialysis Transplantation 2009 24 8 2400 2406 2-s2.0-67651124939 10.1093/ndt/gfp074
48. De Zeeuw D., Remuzzi G., Parving H. H., Keane W. F., Zhang Z., Shahinfar S., Snapinn S., Cooper M. E., Mitch W. E., Brenner B. M., Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004 110 8 921 927 2-s2.0-4344621497 10.1161/01.CIR.0000139860.33974.28 (Pubitemid 39128617)
49. Hemmelgarn B. R., Manns B. J., Lloyd A., James M. T., Klarenbach S., Quinn R. R., Wiebe N., Tonelli M., Relation between kidney function, proteinuria, and adverse outcomes. Journal of the American Medical Association 2010 303 5 423 429 2-s2.0-75849147039 10.1001/jama.2010.39
50. Wright J. T., Bakris G., Greene T., Agodoa L. Y., Appel L. J., Charleston J., Cheek D., Douglas-Baltimore J. G., Gassman J., Glassock R., Hebert L., Jamerson K., Lewis J., Phillips R. A., Toto R. D., Middleton J. P., Rostand S. G., Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. Journal of the American Medical Association 2002 288 19 2421 2431 2-s2.0-0037145856 10.1001/jama.288.19.2421 (Pubitemid 35340538)
51. Ruggenenti P., Perna A., Loriga G., Ganeva M., Ene-Iordache B., Turturro M., Lesti M., Perticucci E., Chakarski I. N., Leonardis D., Garini G., Sessa A., Basile C., Alpa M., Scanziani R., Sorba G., Zoccali C., Remuzzi G., Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. The Lancet 2005 365 9463 939 946 2-s2.0-15844414184 10.1016/S0140-6736(05)71082-5 (Pubitemid 41071427)
52. Badve S. V., Roberts M. A., Hawley C. M., Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. Journal of the American College of Cardiology 2011 58 1152 1161
53. De Nicola L., Minutolo R., Gallo C., Zoccali C., Cianciaruso B., Conte M., Lupo A., Fuiano G., Gallucci M., Bonomini M., Chiodini P., Signoriello G., Bellizi V., Mallamaci F., Nappi F., Conte G., Management of hypertension in chronic kidney disease: The Italian multicentric study. Journal of Nephrology 2005 18 4 397 404 2-s2.0-28244466969 (Pubitemid 41700102)
54. Koomans H. A., Roos J. C., Mees E. J. D., Delawi I. M. K., Sodium balance in renal failure: a comparison of patients with normal subjects under extremes of sodium intake. Hypertension 1985 7 5 714 721 2-s2.0-0021998401 (Pubitemid 15238769)
55. Bellizzi V., Di Iorio B. R., De Nicola L., Minutolo R., Zamboli P., Trucillo P., Catapano F., Cristofano C., Scalfi L., Conte G., Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney International 2007 71 3 245 251 2-s2.0-33846523646 10.1038/sj.ki.5001955 (Pubitemid 46160925)
56. Slagman M. C. J., Waanders F., Hemmelder M. H., Woittiez A. J., Janssen W. M. T., Lambers Heerspink H. J., Navis G., Laverman G. D., Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. British Medical Journal 2011 343 7818 2-s2.0-79961214888 10.1136/bmj.d4366
57. Pimenta E., Gaddam K. K., Oparil S., Aban I., Husain S., Dell'Italia L. J., Calhoun D. A., Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009 54 3 475 481 2-s2.0-70349249634 10.1161/HYPERTENSIONAHA.109. 131235
58. Pettinger W. A., Mitchell H., Renin release, saralasin and the vasodilator beta blocker drug interaction in man. The New England Journal of Medicine 1975 292 23 1214 1217 2-s2.0-0016689197
59. Linas S. L., Nies A. S., Minoxidil. Annals of Internal Medicine 1981 94 1 61 65 2-s2.0-0019350498 (Pubitemid 11218735)
60. Rose B. D., Diuretics. Kidney International 1991 39 2 336 352 2-s2.0-0026011281
61. Dal Canton A., Fuiano G., Conte G., Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clinical Science 1985 68 3 255 261 2-s2.0-0021924235 (Pubitemid 15168961)
62. Fliser D., Schröter M., Neubeck M., Ritz E., Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney International 1994 46 2 482 488 2-s2.0-0028100623 (Pubitemid 24253057)
63. Moser M., Why are physicians not prescribing diuretics more frequently in the management of hypertension? Journal of the American Medical Association 1998 279 22 1813 1816 2-s2.0-0032503682 10.1001/jama.279.22.1813 (Pubitemid 28280254)
64. Gaddam K. K., Nishizaka M. K., Pratt-Ubunama M. N., Pimenta E., Aban I., Oparil S., Calhoun D. A., Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion. Archives of Internal Medicine 2008 168 11 1159 1164 2-s2.0-45149100695 10.1001/archinte.168.11.1159 (Pubitemid 351831398)
65. Vaclavík J., Sedlak R., Plachy M., Navratil K., Plasek J., Jarkovsky J., Vaclavík T., Husar R., Kocianova E., Taborsk M., Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial. Hypertension 2011 57 1069 1075
66. Hering D., Mahfoud F., Walton A. S., Renal denervation in moderate to severe CKD. Journal of the American Society of Nephrology 2012 23 1250 1257
67. Heusser K., Tank J., Engeli S., Diedrich A., Menne J., Eckert S., Peters T., Sweep F. C. G. J., Haller H., Pichlmaier A. M., Luft F. C., Jordan J., Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 2010 55 3 619 626 2-s2.0-77149139150 10.1161/HYPERTENSIONAHA.109.140665